Koyfin Home > Directory > Health Care > Kura Oncology > Capital Expenditures

Kura Oncology Capital Expenditures Chart (KURA)

Kura Oncology annual/quarterly Capital Expenditures from 2014 to 2020.
  • Kura Oncology Capital Expenditures for the quarter ending June 06, 2020 was $-1m a 96.94% decrease of -1m year over year
  • Kura Oncology Capital Expenditures for the last 12 months ending June 06, 2020 was $-1m a 96.99% decrease of -1m year over year
  • Kura Oncology Annual Capital Expenditures for 2015 was $0m a -31.25% increase of 0m from 2014
  • Kura Oncology Annual Capital Expenditures for 2014 was $0m
Other Cash Flow Metrics:
  • Kura Oncology Cash Flow from Operations for the quarter ending December 12, 2018 was $-10m a -25.85% increase of 3m year over year
  • Kura Oncology Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-13m a 43.33% decrease of -6m year over year
View Chart On Koyfin

Quarterly KURA Capital Expenditures Data

06/2020$-1m
03/2020$-1m
12/2015$0m
09/2015$0m
06/2015$0m
03/2015$0m
09/2014$0m

Annual KURA Capital Expenditures Data

2015$0m
2014$0m